MPG.eBooks - Author Search Results

141

Clinical review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for routine prevention of attacks of hereditary angioedema in adolescents and adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

142

CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

143

CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

144

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

145

CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

146

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

147

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

148

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication : for the symptomatic treatment of...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

149

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

150

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

151

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

152

CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

153

CADTH Canadian drug expert committee recommendation: Naltrexone hydrochloride and bupropion hydrochloride (Contrave -- Bausch Health, Canada Inc.) : indication: an adjunct to a red...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

154

CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

155

CADTH Canadian Drug Expert Committee Recommendation: Halobetasol propionate and tazarotene (Duobrii -- Bausch Health, Canada Inc.) : indication : psoriasis, moderate to severe plaq...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

156

CADTH Canadian Drug Expert Committee recommendation: Budesonide (Jorveza--Avir Pharma Inc.) : indication : eosinophilic esophagitis

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

157

CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

158

CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

159

CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

160

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”